The National Foundation for Cancer Research (NFCR) has announced that it will incorporate NexCura Cancer Profiler Tools from Thomson Reuters into its website. The 20 online tools will provide cancer patients with critical, customised information about their treatment options.
The tools were created using patented technology that guides users through a step-by-step questionnaire to match the patient's diagnosis, diagnostic results, and disease stage with the relevant treatment options. All information provided by the NexCura Cancer Profiler Tools is peer-reviewed.
NFCR offers the NexCura Cancer Profiler under the Treatment Decision Tools section of its website (http://www.nfcr.org/patientsupport.com). The NexCura Cancer Profiler claims to be the only online service generating comprehensive treatment information that is personalised for specific diagnoses and clinical status. The customised information enables patients to better communicate with their doctors and care teams and, through education, encourages the patient to play a more proactive role in treatment decisions.
